With technology focused on very different use cases, from cancer fighting to easier parking, here are three interesting tech and biotech startups that recently received funding, along with another company that wants to make your life more well travelled, while still keeping your job.
1.) Nkarta Therapeutics raised $114 Million in a Series B Financing to advance multiple programs into clinical trials. Nkarta is focused on leveraging the natural potent power of NK cells (natural killer cells) to identify and kill abnormal cells. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, as well improve NK recognition of tumor targets and persistence for sustained activity in the body for the treatment of cancer.
